Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00075608 · OUTCOME

Evaluate Immune Reconstitution

2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis · Source last updated 2017-01-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
3 months after treatment and annually

What was measured

Evaluate immune reconstitution based on time to engraftment

Analysis population: No data were collected or analyzed due to study termination

Groups in this outcome

2nd SCT

Mobilization with filgrastim Second autologous peripheral blood stem cell transplant with melphalan conditioning filgrastim: 16mcg/kg IV daily beginning three days prior to SCC through last day of SCC melphalan: 140-200 mcg/kg IV over two days autologous bone marrow transplantation: infusion of previously collected stem cells on Day 0 peripheral blood stem cell transplantation: infusion of previously collected stem cells on Day 0

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
2nd SCT0

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    units
    Participants
description
Evaluate immune reconstitution based on time to engraftment
groups
  1. description
    Mobilization with filgrastim Second autologous peripheral blood stem cell transplant with melphalan conditioning filgrastim: 16mcg/kg IV daily beginning three days prior to SCC through last day of SCC melphalan: 140-200 mcg/kg IV over two days autologous bone marrow transplantation: infusion of previously collected stem cells on Day 0 peripheral blood stem cell transplantation: infusion of previously collected stem cells on Day 0
    id
    OG000
    title
    2nd SCT
population Description
No data were collected or analyzed due to study termination
reporting Status
POSTED
time Frame
3 months after treatment and annually
title
Evaluate Immune Reconstitution
type
PRIMARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice